who_flag

WHO halt coronavirus trials of hydroxychloroquine, lopinavir and ritonavir

July 6, 2020
Sales and Marketing COVID, COVID-19, WHO, coronavirus

The World Health Organization has discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments. This was …

european_commission_web

Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients

July 3, 2020
Medical Communications, Research and Development Europe, Mundipharma, invokana

European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium glucose co-transporter …

racism_protests

US anti-racism protests did not cause spike in coronavirus cases, new study shows

July 3, 2020
Medical Communications COVID-19, coronavirus

Widespread protests against racism and police brutality did not cause a significant spike in coronavirus cases in the US, according …

vaccination-1215279_960_720

Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate

July 3, 2020
Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …

Texas mandates the wearing of facemasks in public

July 3, 2020
Medical Communications COVID-19, coronavirus

Texas becomes the latest state in the US to mandate the wearing of facemasks in public, as COVID-19 cases skyrocket …

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …

shutterstock_38078521

EUSA Pharma gets FDA green light to evaluate IL-6 inhibitor siltuximab in COVID-19 patients

July 2, 2020
Research and Development COVID-19, Eusa Pharma, siltuximab

Efforts push on to discover an effective treatment for COVID-19 in more than 100 different drug candidates worldwide. EUSA Pharma …

london-railway-station-travel

COVID-19 immunity may be more widespread than previously thought, new study suggests

July 2, 2020
Business Services coronaviurs, covid-29, herd immunity

Coronavirus immunity in the world’s population may be more widespread than initially thought, even in those who have tested negative …

ebola_vaccine

European Commission announces approval for Janssen’s Ebola vaccine

July 2, 2020
Business Services EC, Ebola, Ebola Vaccines

Johnson & Johnson announced that the European Commission has granted Marketing Authorisation for its Janssen Ebola vaccine. Two Marketing Authorisation …

novo

Drug industry suing to overturn Minnesota insulin affordability law

July 2, 2020
Business Services diabetes, insulin, type 1, type 2

The drug industry is suing to overturn a Minnesota law that requires companies to provide emergency insulin to diabetics who …

FDA approves Pfizer and Merck KGaA’s Bavencio for maintenance of advanced bladder cancer

July 1, 2020
Research and Development, Sales and Marketing Bavencio FDA, EMD Serono, Merck, Pfier

The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …

takeda_world

Takeda partners up with Carmine Therapeutics to develop and market rare disease candidates

July 1, 2020
Research and Development Takeda Carmine, partnership, pharma

Takeda has linked up with Carmine Therapeutics in a new partnership to discover, develop and bring to market new non-viral …

covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 1, 2020
Research and Development COVID-19, coronavirus

COVID-19 vaccines dominate this week’s news cycle, with Vaxart announcing the selection of its lead candidate for COVID-19 by Operation …

vacinnenenen

US buys most of the world’s stock of COVID-19 drug remdesivir

July 1, 2020
Research and Development COVID-19, coronavirus

The US has bought most of the world’s stock of the drug remdesivir which is one of the only drugs …

fda

FDA says COVID-19 vaccine would need to be at least 50% effective to be approved

July 1, 2020
Research and Development COVID-19, FDA, coronavirus

The FDA announced that any COVID-19 vaccine that gets approval must show that it is at least 50% more effective …

vaccinessssssssssssssssssss

India to go ahead with human trials of COVID-19 vaccine in July

June 30, 2020
Manufacturing and Production COVID-19, Vaccine, coronavirus

A trial of a new Indian made vaccine will begin testing in humans from July. The vaccine is called Covaxin …

roche

Roche’s Phesgo combo secures US approval for metastatic HER2-positive breast cancer

June 30, 2020
Manufacturing and Production, Sales and Marketing FDA, Phesgo, Roche, US, breast cancer

The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with …

New swine flu with pandemic potential identified in China

June 30, 2020
Manufacturing and Production flu, flu pandemic, swine flu

A new strain of flu has emerged in pigs in China, with scientists warning it has pandemic potential. Researchers call …

The Gateway to Local Adoption Series

Latest content